Ulrika Harmenberg

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, David Cella et al. · New England Journal of Medicine · 2013 · 1.9K citations · Full text

Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study

Saeed Dabestani, Andreas Thorstenson, Per Lindblad et al. · World Journal of Urology · 2016 · 278 citations

Urology, Population-based Study, Genitourinary Cancer +6

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025

Bernard Escudier, Robert J. Motzer, Padmanee Sharma et al. · European Urology · 2017 · 233 citations

Checkmate 025, Urology, Genitourinary Cancer +8

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Bernard Escudier, Jan Roigas, Silke Gillessen et al. · Journal of Clinical Oncology · 2009 · 207 citations · Full text

2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

Pirkko‐Liisa Kellokumpu‐Lehtinen, Ulrika Harmenberg, Timo Joensuu et al. · The Lancet Oncology · 2013 · 205 citations

Urology, Oncology, Genitourinary Cancer +5